Drug
Arimoclomol clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 6
- first study started
- 2005
How studies write it
Studies that test it under each name
Name
Studies by the year they started
9 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 7
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 2
ZevraDenmark (6) · CytRx (2) · University of Miami (1) · Richard Barohn, MD (1)
Studies
Open first, then newest update. How each study uses arimoclomol is read from its arms, and is right about nine times in ten.
Testing it · 10
- Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type CCompletedPhase 2/3ZevraDenmarkNCT02612129Written as arimoclomol
- Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension TrialTerminatedPhase 3ZevraDenmarkNCT04049097Written as Arimoclomol
- Arimoclomol in Amyotropic Lateral SclerosisCompletedPhase 3ZevraDenmarkNCT03491462Written as Arimoclomol
- Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension TrialTerminatedPhase 3ZevraDenmarkNCT03836716Written as Arimoclomol
- Study of Arimoclomol in Inclusion Body Myositis (IBM)CompletedPhase 2ZevraDenmarkNCT02753530Written as Arimoclomol
- Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3TerminatedPhase 2ZevraDenmarkNCT03746587Written as Arimoclomol
- Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral SclerosisCompletedPhase 2/3University of MiamiNCT00706147Written as Arimoclomol
- Arimoclomol in Sporadic Inclusion Body MyositisCompletedPhase 2/3Richard Barohn, MDNCT00769860Written as Arimoclomol
- A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALSCompletedPhase 2CytRxNCT00244244Written as arimoclomol
- A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALSWithdrawnPhase 2CytRxNCT00561366Written as Arimoclomol
Codes
What other systems call arimoclomol · ClinicalTrials.gg INT004646
- MeSH (NLM) C486387arimoclomolOne source NLM
- UNII (FDA) EUT3557RT5ARIMOCLOMOLConfirmed FDA, NLM, Wikidata
- Wikidata Q4790694ArimoclomolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C79744ArimoclomolOne source FDA
- DrugBank DB05025One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C486387 | arimoclomol | One source NLM |
| UNII (FDA) | EUT3557RT5 | ARIMOCLOMOL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4790694 | Arimoclomol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C79744 | Arimoclomol | One source FDA |
| DrugBank | DB05025 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.